Self-care products set to grow big, says Haleon CEO
healthcare following the pandemic is leading to robust growth in opportunity for businesses, and consumers are definitely not downtrading on health, said Brian McNamara, global chief executive of Haleon, the consumer healthcare company spun off from GlaxoSmithKline Consumer.
Last year, British consumer healthcare company GSK had separated its consumer healthcare business from GSK Group to form Haleon, an independent listed company that sells non-prescription drugs, vitamins and oral care products.
Enhance Your Healthcare Expertise with High-Impact Courses
Offering CollegeCourseWebsiteIndian School of BusinessISB Healthcare ManagementVisitIIM KozhikodeIIMK Healthcare Management & Analytics ProgrammeVisit«People's interest in everyday health and wellness is continuing. This growing focus, an emerging middle class and sizeable unmet needs are where we can innovate and provide products in a sector that's really poised for growth,» McNamara told ET.
Haleon, the maker of Sensodyne toothpaste, Centrum health supplements, Crocin tablets and Iodex pain relief balm, is seeing consumers a lot more interested in proactively managing health, which is a Covid-19 dynamic that's stuck, McNamara said.
«The other big trend is governments worldwide too are under pressure in their healthcare systems and, hence, are promoting the role that self-care can play to treat minor ailments, to take that pressure off the healthcare system,» he said.
«In India, too, during the entire Covid-19 pandemic, the government messaging has been very clear, with self-care with programmes like Ayushman Bharat.»
Haleon, which counts the US, China and India as its top priority markets, is betting on India's 1.4 billion population as a market that's primed for
